| Trial ID: | L0914 |
| Source ID: | NCT01219413
|
| Associated Drug: |
Aliskiren, Perindopril
|
| Title: |
Influence of Aliskiren on Proteinuria
|
| Acronym: |
ALIPRES
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Proteinuria|Blood Pressure
|
| Interventions: |
DRUG: Aliskiren, Perindopril
|
| Outcome Measures: |
Primary: Investigate the antiproteinuric effect of adding aldosterone antagonist, spironolactone to the combination therapy with angiotensin converting enzyme inhibitor and AT-1 receptor blocker in maximal recommended doses. reduction of proteinuria, march 2014 - april 2014 | Secondary: reduction of blood pressure, march 2013 - april 2014
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Gdansk
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-03
|
| Completion Date: |
2010-09
|
| Results First Posted: |
|
| Last Update Posted: |
2015-09-24
|
| Locations: |
Medical University of Gdansk, Gdansk, Pomorskie, 80-211, Poland
|
| URL: |
https://clinicaltrials.gov/show/NCT01219413
|
